Cargando…

A protocol for an international, multicentre pharmacokinetic study for Screening Antifungal Exposure in Intensive Care Units: The SAFE-ICU study

OBJECTIVE: To describe whether contemporary dosing of antifungal drugs achieves therapeutic exposures in critically ill patients that are associated with optimal outcomes. Adequate antifungal therapy is a key determinant of survival of critically ill patients with fungal infections. Critical illness...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roberts, Jason A., Sime, Fekade, Lipman, Jeffrey, Hernández-Mitre, Maria Patricia, Baptista, João Pedro, Brüggemann, Roger J., Darvall, Jai, De Waele, Jan J., Dimopoulos, George, Lefrant, Jean-Yves, Mat Nor, Mohd Basri, Rello, Jordi, Seoane, Leonardo, Slavin, Monica A., Valkonen, Miia, Venditti, Mario, Wong, Wai Tat, Zeitlinger, Markus, Roger, Claire
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Special Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581271/ https://www.ncbi.nlm.nih.gov/pubmed/37876989 http://dx.doi.org/10.1016/j.ccrj.2023.04.002

Ejemplares similares

Challenges in Antifungal Therapy in Diabetes Mellitus
por: Mohd Sazlly Lim, Sazlyna, et al.
Publicado: (2020)

How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?
por: Wong, Gloria, et al.
Publicado: (2014)

Fundament and Prerequisites for the Application of an Antifungal TDM Service
por: Brüggemann, Roger J. M., et al.
Publicado: (2015)

Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review
por: Sime, Fekade Bruck, et al.
Publicado: (2012)

1573. Population Pharmacokinetic Analyses for Cefepime in Adult and Pediatric Patients
por: Liu, Jiajun, et al.
Publicado: (2019)

DALI: Defining Antibiotic Levels in Intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic
por: Roberts, Jason A, et al.
Publicado: (2012)

Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients
por: Sime, Fekade B., et al.
Publicado: (2018)

Procalcitonin Clearance for Early Prediction of Survival in Critically Ill Patients with Severe Sepsis
por: Mat Nor, Mohd Basri, et al.
Publicado: (2014)

Mechanisms of Antifungal Properties of Metal Nanoparticles
por: Slavin, Yael N., et al.
Publicado: (2022)

Repurposing antifungals: population pharmacokinetics of itraconazole and hydroxy-itraconazole following administration of a nanocrystal formulation
por: Jansen, Anouk M E, et al.
Publicado: (2023)

Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B
por: Adler-Moore, Jill, et al.
Publicado: (2019)

Development of Population and Bayesian Models for Applied Use in Patients Receiving Cefepime
por: Liu, Jiajun, et al.
Publicado: (2020)

A Population Pharmacokinetic Model-Guided Evaluation of Ceftolozane-Tazobactam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration
por: Sime, Fekade B., et al.
Publicado: (2019)

Population Pharmacokinetics of Unbound Ceftolozane and Tazobactam in Critically Ill Patients without Renal Dysfunction
por: Sime, Fekade B., et al.
Publicado: (2019)

Impact of the Epithelial Lining Fluid Milieu on Amikacin Pharmacodynamics Against Pseudomonas aeruginosa
por: Heffernan, Aaron J., et al.
Publicado: (2021)

Cerebrospinal Fluid Penetration of Ceftolozane-Tazobactam in Critically Ill Patients with an Indwelling External Ventricular Drain
por: Sime, Fekade B., et al.
Publicado: (2020)

Dynamic Changes of Plasma Neutrophil Gelatinase-Associated Lipocalin Predicted Mortality in Critically Ill Patients with Systemic Inflammatory Response Syndrome
por: Ralib, Azrina Md, et al.
Publicado: (2017)

Pharmacodynamics of Aerosolized Fosfomycin and Amikacin against Resistant Clinical Isolates of Pseudomonas aeruginosa and Klebsiella pneumoniae in a Hollow-Fiber Infection Model: Experimental Basis for Combination Therapy
por: Sime, Fekade Bruck, et al.
Publicado: (2016)

Population pharmacokinetics of total and unbound concentrations of intravenous posaconazole in adult critically ill patients
por: Sime, Fekade B., et al.
Publicado: (2019)

Risk stratification of individuals undergoing surgery after COVID-19 recovery
por: Silvapulle, Earlene, et al.
Publicado: (2022)

Strengthening ICU health security for a coronavirus epidemic
por: Jansson, Miia, et al.
Publicado: (2020)

Ex Vivo Characterization of Effects of Renal Replacement Therapy Modalities and Settings on Pharmacokinetics of Meropenem and Vaborbactam
por: Sime, Fekade B., et al.
Publicado: (2018)

Candida isolates from pregnant women and their antifungal susceptibility in a Malaysian tertiary-care hospital
por: Masri, Siti Norbaya, et al.
Publicado: (2015)

Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study
por: Blot, Stijn, et al.
Publicado: (2014)

Evaluation of Global trigger tool as a medication safety tool for adverse drug event detection—a cross-sectional study in a tertiary hospital
por: Valkonen, Ville, et al.
Publicado: (2023)

Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study
por: Sinnollareddy, Mahipal G, et al.
Publicado: (2015)

Sepsis and Its Impact on Outcomes in Elderly Patients Admitted to a Malaysian Intensive Care Unit
por: Wan Muhd Shukeri, Wan Fadzlina, et al.
Publicado: (2022)

The Utility of the Creatinine Excretion to Production Ratio and the Plasma Creatinine and Cystatin C Based Kinetic Estimates of Glomerular Filtration Rates in Critically Ill Patients with Sepsis
por: Md Ralib, Azrina, et al.
Publicado: (2022)

Diagnosis and management of temperature abnormality in ICUs: a EUROBACT investigators' survey
por: Niven, Daniel J, et al.
Publicado: (2013)

The battle against fungi: lessons in antifungal stewardship from COVID 19 times()
por: Kanj, Souha S., et al.
Publicado: (2023)

Artificial Intelligence for clinical decision support in Critical Care, required and accelerated by COVID-19
por: Jansson, Miia, et al.
Publicado: (2020)

Pneumonia in the tropics: Report from the Task Force on tropical diseases by the World Federation of Societies of Intensive and Critical Care Medicine
por: Nor, Mohd Basri Mat, et al.
Publicado: (2017)

Interrater reliability of the Clinical Frailty Scale in the anesthesia preadmission clinic
por: Reilly, Jennifer, et al.
Publicado: (2023)

Editorial: Pharmacokinetics, pharmacodynamics (PK/PD) of antibiotics: A reality check
por: Zeitlinger, Markus, et al.
Publicado: (2023)

High frequency oscillatory ventilation in leptospirosis pulmonary hemorrhage syndrome: A case series study
por: Mat Nor, Mohd Basri, et al.
Publicado: (2016)

Long-term Survival of Critically Ill Patients Stratified According to Pandemic Triage Categories: A Retrospective Cohort Study
por: Darvall, Jai N., et al.
Publicado: (2021)

Estimating the incidence of spontaneous breathing effort of mechanically ventilated patients using a non-linear auto regressive (NARX) model
por: Zainol, Nurhidayah Mohd, et al.
Publicado: (2022)

Tackling the emerging threat of antifungal resistance to human health
por: Fisher, Matthew C., et al.
Publicado: (2022)

How to improve research on management of critically ill patients: Lessons learned from negative randomised clinical trials in the intensive care unit
por: Rello, Jordi, et al.
Publicado: (2020)

Impact of an inducement to give high doses of amikacin and gentamicin on serum concentrations in critically ill patients with severe sepsis
por: Roger, C, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cgain3ji29lsq6tletomepvu7r